Structural basis of HCV neutralization by human monoclonal antibodies resistant to viral neutralization escape.

The high mutation rate of hepatitis C virus allows it to rapidly evade the humoral immune response. However, certain epitopes in the envelope glycoproteins cannot vary without compromising virus viability. Antibodies targeting these epitopes are resistant to viral escape from neutralization and unde...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Thomas Krey, Annalisa Meola, Zhen-Yong Keck, Laurence Damier-Piolle, Steven K H Foung, Felix A Rey
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2013
Materias:
Acceso en línea:https://doaj.org/article/7a34f878544d4b63971ddd2895bc189d
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:7a34f878544d4b63971ddd2895bc189d
record_format dspace
spelling oai:doaj.org-article:7a34f878544d4b63971ddd2895bc189d2021-11-18T06:05:38ZStructural basis of HCV neutralization by human monoclonal antibodies resistant to viral neutralization escape.1553-73661553-737410.1371/journal.ppat.1003364https://doaj.org/article/7a34f878544d4b63971ddd2895bc189d2013-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23696737/pdf/?tool=EBIhttps://doaj.org/toc/1553-7366https://doaj.org/toc/1553-7374The high mutation rate of hepatitis C virus allows it to rapidly evade the humoral immune response. However, certain epitopes in the envelope glycoproteins cannot vary without compromising virus viability. Antibodies targeting these epitopes are resistant to viral escape from neutralization and understanding their binding-mode is important for vaccine design. Human monoclonal antibodies HC84-1 and HC84-27 target conformational epitopes overlapping the CD81 receptor-binding site, formed by segments aa434-446 and aa610-619 within the major HCV glycoprotein E2. No neutralization escape was yet observed for these antibodies. We report here the crystal structures of their Fab fragments in complex with a synthetic peptide comprising aa434-446. The structures show that the peptide adopts an α-helical conformation with the main contact residues F⁴⁴² and Y⁴⁴³ forming a hydrophobic protrusion. The peptide retained its conformation in both complexes, independently of crystal packing, indicating that it reflects a surface feature of the folded glycoprotein that is exposed similarly on the virion. The same residues of E2 are also involved in interaction with CD81, suggesting that the cellular receptor binds the same surface feature and potential escape mutants critically compromise receptor binding. In summary, our results identify a critical structural motif at the E2 surface, which is essential for virus propagation and therefore represents an ideal candidate for structure-based immunogen design for vaccine development.Thomas KreyAnnalisa MeolaZhen-Yong KeckLaurence Damier-PiolleSteven K H FoungFelix A ReyPublic Library of Science (PLoS)articleImmunologic diseases. AllergyRC581-607Biology (General)QH301-705.5ENPLoS Pathogens, Vol 9, Iss 5, p e1003364 (2013)
institution DOAJ
collection DOAJ
language EN
topic Immunologic diseases. Allergy
RC581-607
Biology (General)
QH301-705.5
spellingShingle Immunologic diseases. Allergy
RC581-607
Biology (General)
QH301-705.5
Thomas Krey
Annalisa Meola
Zhen-Yong Keck
Laurence Damier-Piolle
Steven K H Foung
Felix A Rey
Structural basis of HCV neutralization by human monoclonal antibodies resistant to viral neutralization escape.
description The high mutation rate of hepatitis C virus allows it to rapidly evade the humoral immune response. However, certain epitopes in the envelope glycoproteins cannot vary without compromising virus viability. Antibodies targeting these epitopes are resistant to viral escape from neutralization and understanding their binding-mode is important for vaccine design. Human monoclonal antibodies HC84-1 and HC84-27 target conformational epitopes overlapping the CD81 receptor-binding site, formed by segments aa434-446 and aa610-619 within the major HCV glycoprotein E2. No neutralization escape was yet observed for these antibodies. We report here the crystal structures of their Fab fragments in complex with a synthetic peptide comprising aa434-446. The structures show that the peptide adopts an α-helical conformation with the main contact residues F⁴⁴² and Y⁴⁴³ forming a hydrophobic protrusion. The peptide retained its conformation in both complexes, independently of crystal packing, indicating that it reflects a surface feature of the folded glycoprotein that is exposed similarly on the virion. The same residues of E2 are also involved in interaction with CD81, suggesting that the cellular receptor binds the same surface feature and potential escape mutants critically compromise receptor binding. In summary, our results identify a critical structural motif at the E2 surface, which is essential for virus propagation and therefore represents an ideal candidate for structure-based immunogen design for vaccine development.
format article
author Thomas Krey
Annalisa Meola
Zhen-Yong Keck
Laurence Damier-Piolle
Steven K H Foung
Felix A Rey
author_facet Thomas Krey
Annalisa Meola
Zhen-Yong Keck
Laurence Damier-Piolle
Steven K H Foung
Felix A Rey
author_sort Thomas Krey
title Structural basis of HCV neutralization by human monoclonal antibodies resistant to viral neutralization escape.
title_short Structural basis of HCV neutralization by human monoclonal antibodies resistant to viral neutralization escape.
title_full Structural basis of HCV neutralization by human monoclonal antibodies resistant to viral neutralization escape.
title_fullStr Structural basis of HCV neutralization by human monoclonal antibodies resistant to viral neutralization escape.
title_full_unstemmed Structural basis of HCV neutralization by human monoclonal antibodies resistant to viral neutralization escape.
title_sort structural basis of hcv neutralization by human monoclonal antibodies resistant to viral neutralization escape.
publisher Public Library of Science (PLoS)
publishDate 2013
url https://doaj.org/article/7a34f878544d4b63971ddd2895bc189d
work_keys_str_mv AT thomaskrey structuralbasisofhcvneutralizationbyhumanmonoclonalantibodiesresistanttoviralneutralizationescape
AT annalisameola structuralbasisofhcvneutralizationbyhumanmonoclonalantibodiesresistanttoviralneutralizationescape
AT zhenyongkeck structuralbasisofhcvneutralizationbyhumanmonoclonalantibodiesresistanttoviralneutralizationescape
AT laurencedamierpiolle structuralbasisofhcvneutralizationbyhumanmonoclonalantibodiesresistanttoviralneutralizationescape
AT stevenkhfoung structuralbasisofhcvneutralizationbyhumanmonoclonalantibodiesresistanttoviralneutralizationescape
AT felixarey structuralbasisofhcvneutralizationbyhumanmonoclonalantibodiesresistanttoviralneutralizationescape
_version_ 1718424611793666048